|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets: | |||||||||
| Cash, cash equivalents and restricted cash | |||||||||
| Trade receivables, net of allowance for expected credit losses of $25.5 and $20.5 as of September 30, 2026 and December 31, 2025, respectively | |||||||||
| Inventories | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Current assets held for sale | |||||||||
| Total current assets | |||||||||
| Property, plant and equipment, net | |||||||||
| Operating lease right-of-use-assets, net | |||||||||
| Goodwill | |||||||||
| Intangible assets, net | |||||||||
| Other non-current assets | |||||||||
| Non-current assets held for sale | |||||||||
| Total assets | |||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||
| Current Liabilities: | |||||||||
| Current portion of long-term debt | |||||||||
| Trade payables | |||||||||
| Related Party | |||||||||
| Total trade payables | |||||||||
| Accruals and other current liabilities | |||||||||
| Related Party | |||||||||
| Total accruals and other current liabilities | |||||||||
| Current portion of operating lease obligations | |||||||||
| Current liabilities held for sale | |||||||||
| Total current liabilities | |||||||||
| Long-term debt, less current portion | |||||||||
| Operating lease obligations, less current portion | |||||||||
| Deferred income taxes | |||||||||
| Other non-current liabilities | |||||||||
| Non-current liabilities held for sale | |||||||||
| Total liabilities | |||||||||
| Stockholders' Equity: | |||||||||
| Preferred stock, $0.01 and $0.001 par value, nil and $1,000 stated value, 100,000,000 and 250,000 shares authorized at December 31, 2024 and 2023, respectively, nil issued and outstanding at December 31, 2024 and 2023 | |||||||||
| Common stock, $0.01 par value, 900,000,000 shares authorized, 361,681,686 and 363,940,940 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Accumulated other comprehensive loss | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...